Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DROXIDOPA vs DURVALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DROXIDOPA vs DURVALUMAB: Safety Overview

Metric DROXIDOPA DURVALUMAB
Total FAERS Reports 20,119 17,142
Deaths Reported 2,500 5,088
Death Rate 12.4% 29.7%
Hospitalizations 2,900 5,968
Average Patient Age 67.7 yrs 65.7 yrs
% Female Patients 46.7% 35.1%
FDA Approval Date Apr 28, 2021 N/A
Manufacturer Aurobindo Pharma Limited AstraZeneca Pharmaceuticals LP
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription